Umesha K. Bhadraiah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Umesha K. Bhadraiah has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chandramouli Manasa
Department of Chemistry, Vidyavardhaka College of Engineering, Visvesvaraya Technological University, Mysore 570 002, Karnataka, India
1 shared publication - Dileep Chikkur Shanthakumar
Department of Studies in Physics, Manasagangotri, University of Mysore, Mysore 570 006, India
1 shared publication - Manjunatha C. Ramegowda
University of Mysore
1 shared publication - Siddesh M. Basavaraja
Department of Chemistry, KLE Society’s SK Arts College and HSK Science Institute, Hubballi 580031, Karnataka, India
1 shared publication - Srikantamurthy Ningaiah
Department of Chemistry, Vidyavardhaka College of Engineering, Visvesvaraya Technological University, Mysuru-570002, Karnataka, India
1 shared publication - Vrushabendra Basavanna
Visvesvaraya Technological University
1 shared publication
Latest Publications
- Open Access
- 19 December 2023
- Published by MDPI AG in Engineering Proceedings
- Vol. 59 (1) , 70
Novel Class of Benzimidazoles: Synthesis, Characterization and Pharmaceutical Evaluation
The wide range of biological processes and functions that benzimidazole moieties can be used for makes them very interesting synthetic molecules. A novel class of scaffolds for benzimidazole heterocycles has been successfully constructed in the present study and synthesized by using the starting material of O-phenylenediamine derivatives (1a–c). The 1-methyl-2-(methylthio)-1H-benzo[d]imidazole derivatives (3a–c) have been synthesized as intermediate compounds by treating the precursors (1a–c) with carbon disulfide followed by N- and S-methylation with iodomethane and anhydrous potassium carbonate. In the latter step, the intermediate molecules were converted into benzimidazole-containing methyl-piperazine (4a–c), piperazin-ol tethered benzimidazoles (5a–c), and phenylpiperazine holding benzimidazoles (6a–c). The structures assigned to target compounds have been analyzed and confirmed via IR, NMR, and MS analysis. The antibacterial, anthelmintic, and anticancer properties of the target compounds were examined. The biological study showed that the compounds 6b, 4c, and 5a emerge as excellent antibacterial, antifungal, and anthelmintic agents, respectively, whereas heterocycle 6a showed excellent anticancer activity against hepatocyte-derived cell line HUH7, as well as the MCF7 breast cancer cell line with IC50 values of 6.41 and 9.70 µg/mL, respectively. The discovery of a novel class of hetero compounds with multiple hetero moieties that may aid in medication design is also highlighted in this study.
- 19 December 2023
- Published by MDPI AG in Engineering Proceedings
- Vol. 59 (1) , 70
Open AccessNovel Class of Benzimidazoles: Synthesis, Characterization and Pharmaceutical Evaluation
The wide range of biological processes and functions that benzimidazole moieties can be used for makes them very interesting synthetic molecules. A novel class of scaffolds for benzimidazole heterocycles has been successfully constructed in the present study and synthesized by using the starting material of O-phenylenediamine derivatives (1a–c). The 1-methyl-2-(methylthio)-1H-benzo[d]imidazole derivatives (3a–c) have been synthesized as intermediate compounds by treating the precursors (1a–c) with carbon disulfide followed by N- and S-methylation with iodomethane and anhydrous potassium carbonate. In the latter step, the intermediate molecules were converted into benzimidazole-containing methyl-piperazine (4a–c), piperazin-ol tethered benzimidazoles (5a–c), and phenylpiperazine holding benzimidazoles (6a–c). The structures assigned to target compounds have been analyzed and confirmed via IR, NMR, and MS analysis. The antibacterial, anthelmintic, and anticancer properties of the target compounds were examined. The biological study showed that the compounds 6b, 4c, and 5a emerge as excellent antibacterial, antifungal, and anthelmintic agents, respectively, whereas heterocycle 6a showed excellent anticancer activity against hepatocyte-derived cell line HUH7, as well as the MCF7 breast cancer cell line with IC50 values of 6.41 and 9.70 µg/mL, respectively. The discovery of a novel class of hetero compounds with multiple hetero moieties that may aid in medication design is also highlighted in this study.